Glaukos Corp Stock Market Outlook
| GKOS Stock | USD 106.64 2.83 2.59% |
Slightly above 57% of Glaukos Corp's investor base is looking to short. The analysis of overall sentiment of trading Glaukos Corp stock suggests that many investors are alarmed at this time. Glaukos Corp's investing sentiment can be driven by a variety of factors including economic data, Glaukos Corp's earnings reports, geopolitical events, and overall market trends.
Comfort Level 43
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Glaukos Corp's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Glaukos Corp.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Given the investment horizon of 90 days and your way above-average risk tolerance, our recommendation regarding Glaukos Corp is 'Strong Buy'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Glaukos Corp given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Glaukos Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Execute Glaukos Corp Advice
The Glaukos recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Glaukos Corp. Macroaxis does not own or have any residual interests in Glaukos Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Glaukos Corp's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Mild | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
For the selected time horizon Glaukos Corp has a Risk Adjusted Performance of 0.095, Jensen Alpha of 0.2485, Total Risk Alpha of 0.1399, Sortino Ratio of 0.1127 and Treynor Ratio of 0.3505Macroaxis provides investment recommendation on Glaukos Corp to complement and cross-verify current analyst consensus on Glaukos Corp. Our trade recommendations engine determines the entity's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Glaukos Corp is not overpriced, please check out all Glaukos Corp fundamentals, including its shares outstanding, net income, price to earnings to growth, as well as the relationship between the price to book and current ratio . Given that Glaukos Corp has a price to earning of 94.70 X, we strongly advise you to confirm Glaukos Corp market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.
Glaukos Corp Trading Alerts and Improvement Suggestions
| The company reported the previous year's revenue of 383.48 M. Net Loss for the year was (146.37 M) with profit before overhead, payroll, taxes, and interest of 361.14 M. | |
| Glaukos Corp currently holds about 391.19 M in cash with (61.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.22. | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: How Teleflexs Sudden CEO Exit and Fraud Probe Will Impact Teleflex Investors |
Glaukos Corp Returns Distribution Density
The distribution of Glaukos Corp's historical returns is an attempt to chart the uncertainty of Glaukos Corp's future price movements. The chart of the probability distribution of Glaukos Corp daily returns describes the distribution of returns around its average expected value. We use Glaukos Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Glaukos Corp returns is essential to provide solid investment analysis for Glaukos Corp.
| Mean Return | 0.29 | Value At Risk | -3.93 | Potential Upside | 5.03 | Standard Deviation | 2.65 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Glaukos Corp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Glaukos Stock Institutional Investors
The Glaukos Corp's institutional investors refer to entities that pool money to purchase Glaukos Corp's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | William Blair Investment Management, Llc | 2025-06-30 | 1.1 M | Hhg Plc | 2025-06-30 | 1.1 M | Holocene Advisors, Lp | 2025-06-30 | 1 M | Amvescap Plc. | 2025-06-30 | 997.1 K | Capital World Investors | 2025-06-30 | 850.9 K | Norges Bank | 2025-06-30 | 738.8 K | Point72 Asset Management, L.p. | 2025-06-30 | 719.3 K | Gilder Gagnon Howe & Co Llc | 2025-06-30 | 700.6 K | Charles Schwab Investment Management Inc | 2025-06-30 | 700.5 K | Blackrock Inc | 2025-06-30 | 8.7 M | Fmr Inc | 2025-06-30 | 6.3 M |
Glaukos Corp Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change To Inventory | (7.7M) | (15.5M) | (4.8M) | (18.8M) | (16.9M) | (16.1M) | |
| Change In Cash | 4.1M | 18.8M | (26.1M) | 76.2M | 87.6M | 92.0M | |
| Free Cash Flow | (23.1M) | (63.3M) | (78.0M) | (67.6M) | (60.9M) | (57.8M) | |
| Depreciation | 34.4M | 35.9M | 38.0M | 39.9M | 45.9M | 48.2M | |
| Other Non Cash Items | 7.2M | 5.1M | 5.7M | 34.6M | 39.8M | 41.8M | |
| Capital Expenditures | 47.8M | 30.3M | 20.2M | 6.3M | 7.2M | 12.0M | |
| Net Income | (49.6M) | (99.2M) | (134.7M) | (146.4M) | (131.7M) | (125.1M) | |
| End Period Cash Flow | 100.7M | 119.5M | 93.5M | 169.6M | 195.1M | 204.8M | |
| Investments | (8.4M) | 75.9M | 43.7M | 47.8M | 55.0M | 57.8M | |
| Net Borrowings | (659K) | (527K) | (711K) | (1.6M) | (1.8M) | (1.7M) | |
| Change To Netincome | 37.0M | 45.6M | 34.9M | 40.8M | 46.9M | 26.9M | |
| Change Receivables | (6.6M) | 2.2M | 1.7M | (3.1M) | (3.6M) | (3.8M) |
Glaukos Corp Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Glaukos Corp or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Glaukos Corp's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Glaukos stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.25 | |
β | Beta against Dow Jones | 0.81 | |
σ | Overall volatility | 2.62 | |
Ir | Information ratio | 0.09 |
Glaukos Corp Volatility Alert
Glaukos Corp currently demonstrates below-average downside deviation. It has Information Ratio of 0.09 and Jensen Alpha of 0.25. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Glaukos Corp's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Glaukos Corp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Glaukos Corp Fundamentals Vs Peers
Comparing Glaukos Corp's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Glaukos Corp's direct or indirect competition across all of the common fundamentals between Glaukos Corp and the related equities. This way, we can detect undervalued stocks with similar characteristics as Glaukos Corp or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Glaukos Corp's fundamental indicators could also be used in its relative valuation, which is a method of valuing Glaukos Corp by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Glaukos Corp to competition |
| Fundamentals | Glaukos Corp | Peer Average |
| Return On Equity | -0.12 | -0.31 |
| Return On Asset | -0.0574 | -0.14 |
| Profit Margin | (0.19) % | (1.27) % |
| Operating Margin | (0.12) % | (5.51) % |
| Current Valuation | 6.12 B | 16.62 B |
| Shares Outstanding | 57.43 M | 571.82 M |
| Shares Owned By Insiders | 3.47 % | 10.09 % |
| Shares Owned By Institutions | 96.53 % | 39.21 % |
| Number Of Shares Shorted | 2.48 M | 4.71 M |
| Price To Earning | 94.70 X | 28.72 X |
| Price To Book | 8.17 X | 9.51 X |
| Price To Sales | 13.38 X | 11.42 X |
| Revenue | 383.48 M | 9.43 B |
| Gross Profit | 361.14 M | 27.38 B |
| EBITDA | (95.64 M) | 3.9 B |
| Net Income | (146.37 M) | 570.98 M |
| Cash And Equivalents | 391.19 M | 2.7 B |
| Cash Per Share | 8.22 X | 5.01 X |
| Total Debt | 105.87 M | 5.32 B |
| Debt To Equity | 0.68 % | 48.70 % |
| Current Ratio | 6.78 X | 2.16 X |
| Book Value Per Share | 13.41 X | 1.93 K |
| Cash Flow From Operations | (61.32 M) | 971.22 M |
| Short Ratio | 2.93 X | 4.00 X |
| Earnings Per Share | (1.54) X | 3.12 X |
| Price To Earnings To Growth | 1.64 X | 4.89 X |
| Target Price | 132.71 | |
| Number Of Employees | 995 | 18.84 K |
| Beta | 0.7 | -0.15 |
| Market Capitalization | 6.29 B | 19.03 B |
| Total Asset | 974.76 M | 29.47 B |
| Retained Earnings | (745.44 M) | 9.33 B |
| Working Capital | 374.67 M | 1.48 B |
Note: Disposition of 166000 shares by Thomas Burns of Glaukos Corp at 30.92 subject to Rule 16b-3 [view details]
Glaukos Corp Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Glaukos . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 58504.79 | |||
| Daily Balance Of Power | (0.54) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 109.18 | |||
| Day Typical Price | 108.33 | |||
| Price Action Indicator | (3.95) | |||
| Period Momentum Indicator | (2.83) |
Glaukos Corp Target Price Consensus
Glaukos target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Glaukos Corp's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 15 | Strong Buy |
Most Glaukos analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Glaukos stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Glaukos Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationGlaukos Corp Target Price Projection
Glaukos Corp's current and average target prices are 106.64 and 132.71, respectively. The current price of Glaukos Corp is the price at which Glaukos Corp is currently trading. On the other hand, Glaukos Corp's target price is what analysts think the stock is worth. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Glaukos Corp Market Quote on 18th of February 2026
Target Price
Analyst Consensus On Glaukos Corp Target Price
Glaukos Corp Analyst Ratings
Glaukos Corp's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Glaukos Corp stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Glaukos Corp's financials, market performance, and future outlook by experienced professionals. Glaukos Corp's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
About Glaukos Corp Buy or Sell Advice
When is the right time to buy or sell Glaukos Corp? Buying financial instruments such as Glaukos Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Glaukos Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Health Care ETFs Thematic Idea Now
Health Care ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Health Care ETFs theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Care ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Glaukos Stock Analysis
When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.